US Patent 9738727 Anti-HtrA1 antibodies and methods of use
Patent 9738727 was granted and assigned to Genentech on August, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+90 characters)
Article
Patent abstract
The invention provides anti-HtrA1 antibodies and methods of using the same.
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Daniel Kirchhofer0
Kenneth J. Katschke, Jr.0
Menno van Lookeren-Campagne0
Michael Terry Lipari0
Paul M. Moran0
Scott Stawicki0
Wei-Ching Liang0
Yan Wu0
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09738727 Anti-HtrA1 antibodies and methods of use US Patent 9738727 Anti-HtrA1 antibodies and methods of use
Infobox
Patent Number
097387270
Patent Number
97387270
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
097387270
Date of Patent
August 22, 2017
0Patent Application Number
136512890
Date Filed
October 12, 2012
0Patent Primary Examiner
Edits on 14 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09738727 Anti-HtrA1 antibodies and methods of use
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09738727
Date of patent
August 22, 2017
Patent application number
13651289
Date Filed
October 12, 2012
Patent primary examiner
Find more entities like US Patent 9738727 Anti-HtrA1 antibodies and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.